Aptuit to acquire GSK’s Italian R&D centre
Aptuit is to acquire GSK’s Italian R&D centre, take on its 500 employees and become part of the big pharma’s CRO network.
Archives for July 4, 2010
Sanofi said to be planning $20bn acquisition in US
Rumour has it that French drug giant Sanofi Aventis is planning to make a $20bn (€16bn) acquisition in the US with speculation that biotechs like Allergan, Biogen Idec and Genzyme are among the targets.
Lightweighting and cost saving potential as Mocon upgrades WVTR line
Converters and manufacturers will be able to measure the real-life performance of packaging barrier products with greater speed and accuracy thanks to an enhanced water vapour transmission rate (WVTR) instrument, said Mocon Inc.
Quintiles setting up first Asian Prime Site in Malaysia
Quintiles is establishing its first Prime Site in Asia by entering into a strategic alliance with the University Malaya Medical Centre (UMMC) in Malaysia.
Abbott exploring sale of vaccines unit
Abbott Laboratories has confirmed it is considering the sale of the vaccines unit it gained with the €4.5bn ($6.2bn) acquisition of Solvay Pharmaceuticals in February.
CRO Clintec opens US office
The opening of a New York office will help communicate Clintec’s global reach to US Pharmaceutical according to new associate director of US business operations, Susan Pavone.
GSK, Singapore to fund research into green production
GlaxoSmithKline (GSK) and the Singapore EDB are to fund eight research projects into green and sustainable production of pharmaceuticals and fine chemicals.
Lilly buys Alnara to move into enzyme drugs
Eli Lilly is moving into the enzyme replacement therapy (ERT) market with the acquisition of US biotechnology firm Alnara Pharmaceuticals.